What we do
The Alzheimer’s Research UK Oxford Drug Discovery Institute is situated in the state-of-the-art Target Discovery Institute at the Univeristy of Oxford Old Road Campus, Headington.
We will couple sophisticated drug discovery capabilities with deep disease-specific expertise in genetics and molecular biology throughout the University and beyond, to identify new druggable targets. We have the knowledge, resources and drive to create lead compounds for neurodegenerative targets and will work closely with industrial partners and private/public funding agencies to ensure successful candidates continue through the drug discovery pipeline towards commercialisation.
We look to forge collaborations with academic and industrial partners as we seek out new targets for neurodegenerative diseases. Find out more about how we can act as a conduit between your research and novel therapeutics.
The Oxford Drug Discovery Institute is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer’s Research UK and launched in 2014. The Oxford Drug Discovery Institute will work alongside Institutes at the University of Cambridge and University College London to create one of the largest coordinated efforts to streamline academic drug discovery into neurodegenerative diseases. Our aim is to meet the unmet clinical need of 850,000 people in the UK and many millions across the world, living with dementia.
If you would like more information about the Alliance, its operation or governance, please contact the Research team at Alzheimer’s Research UK.